Five projects receive Transdisciplinary Initiatives Program awards

The TIP program supports innovative, heterogeneous groups of scholars working to transform one another’s perspective on a child- or maternal-health problem.

The Stanford Child Health Research Institute has awarded $1 million to five research projects through its Transdisciplinary Initiatives Program awards.

The TIP program supports innovative, heterogeneous groups of scholars working to inform one another’s perspective on a child- or maternal-health problem. Teams comprise scientists from preclinical, clinical and basic science fields in the School of Medicine, as well as one or more faculty members from the School of Humanities and Sciences, School of Engineering, School of Business, School of Education, School of Law and School of Earth, Energy and Environmental Sciences.

Following are the titles of the projects and their transdisciplinary teams:

  • “IPSC-derived cardiomyocytes to determine mechanisms by which beta-cardiac myosin mutations cause pediatric hypertrophic cardiomyopathy.” PI: Daniel Bernstein, MD, pediatrics. Co-PIs: Beth Pruitt, PhD, mechanical engineering; James Spudich, PhD, biochemistry; Alexander Dunn, PhD, chemical engineering.
  • “Measuring children’s physical activity and sleep in the real world: Processing and analysis of high-dimensional accelerometry data using statistical learning techniques.” PI: Manisha Desai, PhD, medicine. Co-PIs: Thomas Robinson, MD, pediatrics; Clete Kushida, MD, PhD, psychiatry and behavioral sciences; Scott Delp, PhD, bioengineering, mechanical engineering; Ram Rajagopal, PhD, civil and environmental engineering; Dennis Wall, PhD, pediatrics.
  • “Cerebellar circuitry in development, learning and clinical conditions.” PI: Heidi Feldman, MD, PhD, pediatrics. Co-PIs: Brian Wandell, PhD, psychology; Bruce McCandliss, PhD, education; Kristen Yeom, MD, radiology.
  • “The NSD2 methyltransferase in pediatric ALL.” PI: Or Gozani, MD, PhD, biology. Co-PIs: Julien Sage, PhD, pediatrics, genetics; Justin Dubois, PhD, chemistry; Norman Lacayo, MD, pediatrics.
  • “The role of ALDH2 genetic variation and aldehyde metabolism in hematopoietic stem cell biology and the pathogenesis of bone marrow failure.” PI: Kenneth Weinberg, MD, pediatrics. Co-PIs: Daria Mochly-Rosen, PhD, chemical and systems biology; Eric Kool, PhD, chemistry; Matthew Porteus, MD, PhD, pediatrics.

Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.